Spero Therapeutics – Talk Bio

Actionable Insights Powered by AI

GSK, Spero Report Major Phase 3 Win for UTI Antibiotic; Spero’s Stock Surges

2 months ago talkbio0Tagged Antibiotics, Clinical Trials, Complicated, HBr, PIVOT-PO trial, SmithKline Beecham, Spero Therapeutics, Stock Surge, Submission, United States Food and Drug Administration, Urinary tract infection

GSK; Spero Therapeutics; tebipenem HBr; Phase 3 trial; UTI antibiotic; complicated urinary tract infection; PIVOT-PO trial; stock surge; clinical trial results; FDA submission

Spero Therapeutics Slashes 39% of Workforce Following Phase 2 Antibiotic Trial Failure

9 months ago talkbio0Tagged antibiotic trial, Biotech Layoffs, cash runway extension, Failure (biologic function), Spero Therapeutics

Spero Therapeutics, antibiotic trial failure, workforce reduction, biotech layoffs, cash runway extension